5 Oct 2026
Designing enzymes for new-to-nature chemistry and non-natural substrates with AlphaProtein Novo
Zachary Wuh-index 11, Josh Abramson, Thomas Frerix, Alexander E. Chu, Ruijie K. Zhang, Luca Schulz, Amy E. Danson, Tristan O. C. Kwan, Li Kevin Wenliang, Jacob Kelly, Zi-Qi Li, Rosalia G. Schneider, Ashok Thillaisundaram, Harshnira Patani, Vinicius F. Zambaldi, Sukhdeep Singh, David La, Masy Domecillo, Ariane N. Mora, Julia C. Reisenbauer, Yu Zhang, Eliseo Papa, Akvilė Žemgulytė, Yu-Han Wu, Augustin Žídek, Jiaxin Shi, Grace Margand, Naila Assem, Kate Stephen, Charlie Emrich, Peng Liu, Lucy Colwell, Demis Hassabis, Rob Fergus, Frances H. Arnoldh-index 127, Pushmeet Kohli, Jue Wangh-index 8
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- Crossref1
- OpenCitations0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Creating highly active enzymes for arbitrary reactions is a transformative goal for the molecular sciences 1 . Traditional protein engineering 2,3 is constrained by a reliance on existing natural starting points, which are often challenging to discover. De novo design offers the potential to overcome this by creating enzymes from first principles 4 , but has yet to achieve practically relevant catalytic properties. Here we present AlphaProtein Novo (AP Novo), a machine-learning pipeline that demonstrates, for the first time, that de novo enzyme design can outperform natural sequence mining in addressing challenging chemistry. We used AP Novo to design new-to-nature nitrene transferases to synthesise the pharmacophore piperidine with unprecedented product selectivity, and to create enzymes that degrade the environmental toxin DEHP under conditions that denature natural enzymes. We also obtained state-of-the-art catalytic efficiencies on two well-studied model reactions, and through iterative design and analysis found that key enablers of success were mechanism-inspired metrics based on AlphaFold 3 5 predictions and sequence-ensemble-based scoring of designed backbones. Our results show that de novo design has become a powerful complement to natural enzyme diversity for discovering catalysts for a range of applications.
What the data shows
- Crossref counts 1 citations, the most of the databases. The others count 0.
- Frances H. Arnold has the highest h-index among the authors (127).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (68)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 48 more references
A free account opens the rest of the citing papers and references on every paper’s page.